ArticleFrontiers in oncology2024

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.

Jeffrey J Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.